Bill Arnold
Founding DirectorWilliam ''Bill'' Arnold is a longtime HIV/AIDS activist and consumer organizer and has been active in developing HIV/AIDS organizations and HIV/AIDS policy at the local, state and national level since the mid 1980’s. Arnold is a founding director (1996) of the Community Access National Network (CANN), formerly the Ryan White CARE Act Title II Community AIDS National Network (TIICANN); he is currently its CEO. He is also a founder (1995) of The National ADAP Working Group, a Washington, DC based advocacy coalition of HIV/AIDS organizations.
His involvement with grassroots HIV/AIDS work has included roles...
Source: PHRMA - September 9, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Lawrence Stallworth: What are you excited about in the fight against HIV/AIDS?
When I was 17 years old, I found out I was HIV-positive. As a young, Black gay man, I remember the fear of rejection, and the incredible love and support I found among my family and friends. Since the day I first learned my HIV status, I have made it my personal responsibility to fight this disease until we achieve an AIDS-free generation. I know many young people out there feel the same because our risk of infection is high and access to treatment and care can be tenuous.
In the United States, 39 percent of all new HIV cases are among young people ages 13-29, and from 2007-2010, ages 15-19 and 20-24 were the only age gro...
Source: PHRMA - September 9, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Lawrence Stallworth
Mobile Health Services SpecialistLawrence Stallworth is currently the Mobile Health Services Specialist at the AIDS Taskforce of Greater Cleveland. He is an alum of Advocates for Youth’s Ohio Youth Council and was recently appointed to join the President’s Advisory Council on HIV/AIDS (PACHA) because of his exemplary local and national advocacy work on behalf of young people.
AIDSTaskforceGCAIDSTaskforceGCConversations ContributorsCompany: AIDS Taskforce: Greater Cleveland (Source: PHRMA)
Source: PHRMA - September 9, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Jim Robinson
PresidentJim Robinson is President, Astellas Pharma US Inc, a global research-based pharmaceutical company committed to serving unmet medical needs in Oncology, Immunology, Infectious Diseases, Urology, Neuroscience and DM Complications and Kidney Diseases. Jim leads the company’s commercial pharmaceutical operation in the U.S. which spans across a diverse and growing portfolio in the Oncology, Urology, Transplant and Cardiovascular markets. Jim has over 20 years of experience in the pharmaceutical industry. He is a member of Astellas’ Management Committee. Before assuming his present role, Jim was Sr. Vice President f...
Source: PHRMA - September 2, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news
Holly Campbell
Director, CommunicationsHolly Campbell is a Director of Communications at PhRMA focusing on state health policy and legislative affairs. Prior to joining PhRMA, Holly worked for small and large public relations firms where she provided health care and government clients with strategic communications, media relations, and partnership expertise. In her free time she can be found spoiling her two pups (a boxer and a chihuahua) and exploring all the flea and farmers markets that DC has to offer. Follow Holly on Twitter at @Hlcampbe.
HlcampbeCatalyst ContributorsCompany: PhRMA (Source: PHRMA)
Source: PHRMA - August 19, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Funding for the Science of Informatics
The science of informatics drives innovation that is defining future approaches to information and knowledge management in biomedical research, clinical care, and public health. The PhRMA Foundation Informatics awards promote the development and use of informatics in an integrative approach towards the understanding of human biological and disease processes. Informatics awards will support career development of scientists engaged in research that significantly integrates cutting-edge information technology with advanced biological, chemical, and pharmacological sciences
Awards are available for Pre Doctoral Fellowships, ...
Source: PHRMA - August 18, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
National Psoriasis Foundation on Improving the Lives of Patients
Millions of Americans with psoriatic arthritis—a serious disease that causes pain, swelling and stiffness of the joints and tendons, and can result in joint damage if left untreated—struggle to get the health care and treatments they need to manage their condition. National Psoriasis Foundation plans to change with the largest realignment and expansion of its psoriatic arthritis program.
For nearly two decades, the Psoriasis Foundation has provided disease-management services and information to people with psoriatic arthritis (PsA), which affects as many as one in three people with psoriasis, the most common autoimmune...
Source: PHRMA - August 13, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Npf
PartnerThe National Psoriasis Foundation (NPF) is a non-profit, voluntary health agency dedicated to finding a cure for psoriasis and psoriatic arthritis and eliminating their devastating effects through research, advocacy and education.
Founded in 1968, the Psoriasis Foundation has evolved to become the leading patient advocacy group for the 7.5 million Americans living with psoriasis and psoriatic arthritis.
As emerging research continues to demonstrate the serious, systemic effects of these chronic autoimmune diseases, our highest priority is to find a cure.
NPFNational.Psoriasis.FoundationCompany: Arthritis Co...
Source: PHRMA - August 13, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Gabriela Lavezzari on Improving the Lives of Patients with Arthritis
Many people are unaware of the impact of arthritis and related musculoskeletal diseases in the United States. They affect approximately 52.5 million Americans of all ages, races and genders.
The biopharmaceutical industry is making great strides towards new treatments with 92 medicines in the pipeline which have the potential to help patients live more active and productive lives. Work on these treatments is more imperative than ever as 67 million people could be diagnosed with some form of musculoskeletal disease by 2030, according to the U.S. Centers for Disease Control and Prevention.
Earlier this year, PhRMA joined 10...
Source: PHRMA - August 4, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Stephen I. Katz on Improving the Lives of Patients with Arthritis
To improve the lives of people with arthritis, the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is working toward a better understanding of the basic biology of diseases affecting the joints, better diagnosis and treatment of arthritis, and better tools to facilitate clinical trials.
NIAMS was a key contributor to the development of tofacitinib, the first oral disease modifying antirheumatic drug (DMARD) for rheumatoid arthritis (RA) in a decade, which recently received approval from the U.S. Food and Drug Administration. In the early 1990’s, NIAMS intramural researchers discovered Janu...
Source: PHRMA - July 30, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Amanda Niskar on Improving the Lives of Patients with Arthritis
For almost 70 years, the Arthritis Foundation has initiated and supported scientific discoveries that improve health outcomes for people with arthritis. Research holds the key to finding better diagnostics and treatments—and one day a cure—for more than 50 million Americans who face the daily challenges of arthritis. At the Foundation, we are focused on providing scientific leadership and direction to improve everyday life for people with arthritis and to find a cure.
Information from the Medicines in Development report issued by the Pharmaceutical Research Manufacturers of America (PhRMA), about medicines that are ...
Source: PHRMA - July 30, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
We’ve seen great strides to treat arthritis and related diseases. How do we continue to make headway to improve the lives of patients?
Stephen I. Katz on Improving the Lives of Patients with Arthritis
Submitted by Emily on Wed, 07/30/2014 - 10:22
To improve the lives of people with arthritis, the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is working toward a better understanding of the basic biology of diseases affecting the joints, better diagnosis and treatment of arthritis, and better tools to facilitate clinical trials.
Share
Email
Print
var switchTo5x = false;var __st_loadLate = true;stLight.options({"publisher":"d...
Source: PHRMA - July 30, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
We’ve seen great strides to treat arthritis and related diseases, how do we continue to make headway to improve the lives of patients?
Stephen I. Katz on Improving the Lives of Patients with Arthritis
Submitted by Emily on Wed, 07/30/2014 - 10:22
To improve the lives of people with arthritis, the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is working toward a better understanding of the basic biology of diseases affecting the joints, better diagnosis and treatment of arthritis, and better tools to facilitate clinical trials.
Share
Email
Print
var switchTo5x = false;var __st_loadLate = true;stLight.options({"publisher":"d...
Source: PHRMA - July 30, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Stephen I. Katz
DirectorStephen I. Katz, M.D., Ph.D. has been Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases since August 1995 and is also a Senior Investigator in the Dermatology Branch of the National Cancer Institute. He was born in New York in 1941 and his early years were spent in the Washington, D.C., and Bethesda, Maryland areas. After attending the University of Maryland, where he graduated with honors, he graduated from the Tulane University Medical School with honors in 1966. He completed a medical internship at Los Angeles County Hospital and did his dermatology residency at the University...
Source: PHRMA - July 30, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Amanda Niskar
National Scientific DirectorAs a doctor of public health, Amanda combines her experience in nursing, epidemiology and health policy to successfully bring together crosscutting leaders to make important decisions that turn discoveries into actionable, high-impact programs. She supervises all aspects of the Arthritis Foundation’s scientific program. Amanda is an accomplished author and has received many honors, including international recognition, for research measuring the impact of arthritis on health and well-being. Her accomplishments span the globe, encompassing renowned places such as the Office of the U.S. Secretary...
Source: PHRMA - July 30, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
